BINDING SITE OFFERS ANTIGENS & ANTIBODIES WITH EMPHASIS ON HUMAN COAGULATION APPLICATIONS

SAN DIEGO, CA - Jul 31, 2019 - San Diego, CA . . . . Binding Sites IMMUNOLOGICALS GROUP is pleased announce that it has just completed a major expansion to their antibody and antigen product offerings for human Coagulation testing applications. Both Prothombin and Glycerol-Free Prothombin proteins are now available as antigens, while the antibody products now include Anti-Human Factor H; Factor I; Fibrinogen; Fibronectin; Plasminogen; Prothombin; Thrombin; and von Willebrand Factor. The availability of these antigens and antibodies are certain to help meet the needs of both clinical laboratory professionals and manufacturers of in-vitro diagnostic (IVD) products, but also biopharmaceutical, medical, and life science researchers, as all of the products are designed to work as critical components within a number of enzyme immunoassay testing applications, especially ELISA.

The available antigens exhibit exceptional purity levels as a result of unique chromatographic techniques, while the antibodies demonstrate outstanding degrees of both purity and specificity. Both product lines also feature extended shelf-life stability claims, along with reliable lot-to-lot consistencies, and are shipped with a Certificate-of-Analysis (CoA), for improved record keeping and traceability. All of the products are available in unitized, standard-vial size formats, with bulk packaging and customer-specific manufacturing options available as well.

BINDING SITEs IMMUNOLOGICALS GROUP serves the in-vitro diagnostic (IVD) manufacturing and biopharmaceutical | clinical | life-science | medical research markets with
a comprehensive line of innovative products. For additional information, contact The Binding Site, Inc. at 6730 Mesa Ridge Road, San Diego, CA 92121 USA. Phone: 800-633-4484; FAX: 858-453-9189; Email: info@thebindingsite.com. Please visit our website at www.immunologicals.com.